Literature DB >> 1419749

Distribution of interleukin 1 receptor antagonist protein (IRAP), interleukin 1 receptor, and interleukin 1 alpha in normal and psoriatic skin. Decreased expression of IRAP in psoriatic lesional epidermis.

M Kristensen1, B Deleuran, D J Eedy, M Feldmann, S M Breathnach, F M Brennan.   

Abstract

The distribution of interleukin 1 alpha (IL-1 alpha), type 1 interleukin 1 receptor (IL-1R), and the interleukin 1 receptor antagonist protein (IRAP), was investigated in biopsies of normal skin, and in uninvolved and lesional skin of patients with psoriasis, using specific monoclonal antibodies. We report the novel finding that IRAP is distributed throughout the living layers of the epidermis in normal skin, and is also associated with sebaceous glands and eccrine sweat glands. Our finding that the inhibitor protein IRAP is present in areas where the pro-inflammatory cytokine IL-1 alpha is distributed provides strong evidence in favour of a cytokine regulatory system in normal skin. We further document for the first time that IL-1R in normal skin is localized to the living layers of the epidermis, sebaceous and eccrine glands, as well as to a prominent network of dermal dendritic cells, and upper dermal blood vessels. There was a consistent reduction in the level of IRAP expression in lesional compared with uninvolved skin in biopsies from six out of seven psoriasis patients. Decreased IRAP expression in lesions of psoriasis indicates that alterations in the level of this inhibitor protein may be important in the pathogenesis of inflammatory skin conditions.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1419749     DOI: 10.1111/j.1365-2133.1992.tb00446.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  13 in total

1.  IL-10 is a key cytokine in psoriasis. Proof of principle by IL-10 therapy: a new therapeutic approach.

Authors:  K Asadullah; W Sterry; K Stephanek; D Jasulaitis; M Leupold; H Audring; H D Volk; W D Döcke
Journal:  J Clin Invest       Date:  1998-02-15       Impact factor: 14.808

Review 2.  Autoinflammation: From monogenic syndromes to common skin diseases.

Authors:  Tien V Nguyen; Edward W Cowen; Kieron S Leslie
Journal:  J Am Acad Dermatol       Date:  2013-02-28       Impact factor: 11.527

Review 3.  The skin immune system and psoriasis.

Authors:  S M Breathnach
Journal:  Clin Exp Immunol       Date:  1993-03       Impact factor: 4.330

Review 4.  Modulatory effects of selenium and strontium salts on keratinocyte-derived inflammatory cytokines.

Authors:  P Celerier; A Richard; P Litoux; B Dreno
Journal:  Arch Dermatol Res       Date:  1995       Impact factor: 3.017

5.  Inflammatory and hyperproliferative skin disease in mice that express elevated levels of the IL-1 receptor (type I) on epidermal keratinocytes. Evidence that IL-1-inducible secondary cytokines produced by keratinocytes in vivo can cause skin disease.

Authors:  R W Groves; T Rauschmayr; K Nakamura; S Sarkar; I R Williams; T S Kupper
Journal:  J Clin Invest       Date:  1996-07-15       Impact factor: 14.808

6.  Immunohistochemical identification of type II alternatively activated dendritic macrophages (RM 3/1+3, MS-1+/-, 25F9-) in psoriatic dermis.

Authors:  N Djemadji-Oudjiel; S Goerdt; V Kodelja; M Schmuth; C E Orfanos
Journal:  Arch Dermatol Res       Date:  1996-11       Impact factor: 3.017

7.  Environmental factors and not genotype influence the plasma level of interleukin-1 receptor antagonist in normal individuals.

Authors:  H Cullup; P G Middleton; G Duggan; J S Conn; A M Dickinson
Journal:  Clin Exp Immunol       Date:  2004-08       Impact factor: 4.330

8.  Increased expression of interleukin-4 receptors on psoriatic epidermal cells.

Authors:  E Prens; J Hegmans; R C Lien; R Debets; R Troost; T van Joost; R Benner
Journal:  Am J Pathol       Date:  1996-05       Impact factor: 4.307

9.  Interleukin 1 receptor antagonist gene polymorphism association with lichen sclerosus.

Authors:  F E Clay; M J Cork; J K Tarlow; A I Blakemore; C I Harrington; F Lewis; G W Duff
Journal:  Hum Genet       Date:  1994-10       Impact factor: 4.132

10.  Modulation of the IL-1 cytokine network in keratinocytes by intracellular IL-1 alpha and IL-1 receptor antagonist.

Authors:  W G Phillips; M Feldmann; S M Breathnach; F M Brennan
Journal:  Clin Exp Immunol       Date:  1995-07       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.